BIDIL
Generic: HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE
Azurity PharmaceuticalsManufacturer
ORALRoute
HYDRALAZINE HYDROCHLORIDEActive Substance
2005-06-23Original Approval
BIDIL is FDA application NDA020727, sponsored by AZURITY. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DYSPNOEA
925 reports
2
NAUSEA
823 reports
3
DIARRHOEA
775 reports
4
FATIGUE
763 reports
5
DIZZINESS
754 reports
6
VOMITING
683 reports
7
CHEST PAIN
678 reports
8
PAIN
635 reports
9
MYOCARDIAL INFARCTION
634 reports
10
HEADACHE
627 reports